AESTHETIC device company Syneron Medical has received clearance from the China Food and Drug Administration (CFDA) for its elure Advanced Skin Brightening Lotion.
In a clinical study, the new cosmetic product has been shown lead to significant improvement in skin tone evenness, overall fairness and brightness as early as Day 7. The study was conducted at Peking University First Hospital in China.
The product was originally only available through dermatologists, plastic surgeons and other medical aesthetic providers.
"The People's Republic of China is a core country and focus for elure in Syneron's Asia-Pacific strategy, and the CFDA clearance is the gateway to commercialization,” said Amit Meridor, CEO of Syneron Medical Ltd.
Skin care products are a $9.6-billion market in China, with skin lightening retail revenues estimated at $1.9 billion. Air Jordan 33 XXXIII
Login/Register
Supplier Login
















